Barclays lowered the firm’s price target on XPLR Infrastructure (NEP) to $7 from $17 and keeps an Underweight rating on the shares. The firm ...
NEW YORK CITY, NY / ACCESS Newswire / January 30, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of XPLR ...
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of XPLR Infrastructure, LP ("XPLR" or "the Company") (NYSE: NEP) ...
The software company wants to continue offering more conservative financial guidance than in the past, given the level of ...
AbbVie stock retook its 200-day moving average Friday after the company raised its long-term outlook for Skyrizi and Rinvoq by $4 billion.